GSA Capital Partners’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $727K | Buy |
|
|||||
|
2024
Q3 | $514K | Buy |
|
|||||
|
2024
Q2 | $116K | Buy |
|
|||||
|
2024
Q1 | $158K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $129K | Sell |
|
|||||
|
2023
Q2 | $1.27M | Buy |
|
|||||
|
2023
Q1 | $840K | Buy |
|
|||||
|
2022
Q4 | $189K | Sell |
|
|||||
|
2022
Q3 | $1.13M | Sell |
|
|||||
|
2022
Q2 | $780K | Buy |
|
|||||
|
2022
Q1 | $314K | Sell |
|
|||||
|
2021
Q4 | $542K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $212K | Buy |
|